Repro Med Systems – Consensus Indicates Potential 80.9% Upside

Broker Ratings

Repro Med Systems with ticker code (KRMD) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 16 and 9 and has a mean target at 11.25. Now with the previous closing price of 6.22 this is indicating there is a potential upside of 80.9%. There is a 50 day moving average of 4.93 and the 200 day moving average is 7.6. The company has a market capitalisation of $278m. Visit the company website at: http://www.korumedical.com

Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems was founded in 1980 and is headquartered in Chester, New York.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index